Sosei Group Corp. | Key People and Executives
Peter James Jonathan Bains
President, Chief Executive Officer & Director
Tomohiro Toyama
Outside Director
Kuniaki Kaga
Independent External Director
David Roblin
Independent External Director
Julia P. Gregory
Independent Director
Peter James Jonathan Bains
President, Chief Executive Officer & Director
Chris Cargill
Chief Financial Officer
Tim Tasker
Chief Medical Officer & Executive Vice President
Malcolm Weir
Executive VP, Chief Research & Development Officer
Tomohiro Toyama
Outside Director
Masato Miyauchi
Manager-Accounting
Kieran Johnson
Financial Controller
Kuniaki Kaga
Independent External Director
David Roblin
Independent External Director
Julia P. Gregory
Independent Director
| Address |
PMO Hanzomon, 11/F
Tokyo Tokyo 102
Japan
|
|
Employees
|
- |
| Website |
http://www.sosei.com |
| Updated |
07/08/2019 |
| Sosei Group Corp. engages in the discovery, design, and development of medicines targeting G protein-coupled receptors (GPCRs). Its proprietary StaR (Stabilised Receptor) technology and structure-based drug design (SBDD) platform enables development of drugs for highly validated, yet historically undruggable or challenging GPCRs. The company has multiple programs targeting Alzheimer's disease, schizophrenia, immuno-oncology, migraine, metabolic disease and other rare and specialty indications. |
